DC Field | Value | Language |
dc.contributor.author | Nadezhdin, S. V. | - |
dc.contributor.author | Zubareva, E. V. | - |
dc.contributor.author | Ovsyankin, A. V. | - |
dc.contributor.author | Guzyukina, S. A. | - |
dc.contributor.author | Atamanyuk, E. A. | - |
dc.date.accessioned | 2020-06-04T12:15:48Z | - |
dc.date.available | 2020-06-04T12:15:48Z | - |
dc.date.issued | 2019 | - |
dc.identifier.citation | Influence of recombinant erythropoietin on mesenchymal stem cells proliferation and differentiation during cultivation on allogenic bone matrix / S.V. Nadezhdin, E.V. Zubareva, A.V. Ovsyankin [et al.] // Revista Latinoamericana de Hipertensión. - 2019. - Vol.14, №4.-P. 310-313. | ru |
dc.identifier.uri | http://dspace.bsu.edu.ru/handle/123456789/31413 | - |
dc.description.abstract | Effectiveness of mesenchymal stem cells (MSCs) proliferation and differentiation was studied after addition of medicinal product containing human recombinant erythropoietin (rhEPO) into enriched culture medium with components for osteo- and angiogenesis. Cultivation of mesenchymal stem cells under static conditions using “cocktail” of growth factors and rhEPO allowed to populate allogenic discs-scaffolds with connective tissue formations with the participation of osteoblasts and elongated multicellular structures, which formed after endothelium-like cells fusion | ru |
dc.language.iso | en | ru |
dc.subject | medicine | ru |
dc.subject | pharmacology | ru |
dc.subject | mesenchymal stem cells (MSCs) | ru |
dc.subject | recombinant erythropoietin | ru |
dc.subject | allogenic bone matrix | ru |
dc.subject | proliferation | ru |
dc.subject | differentiation | ru |
dc.title | Influence of recombinant erythropoietin on mesenchymal stem cells proliferation and differentiation during cultivation on allogenic bone matrix | ru |
dc.type | Article | ru |
Appears in Collections: | Статьи из периодических изданий и сборников (на иностранных языках) = Articles from periodicals and collections (in foreign languages)
|